Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia.
about
Preparing for the first breath: genetic and cellular mechanisms in lung developmentEndogenous and Exogenous Stem/Progenitor Cells in the Lung and Their Role in the Pathogenesis and Treatment of Pediatric Lung DiseaseThe Extracellular Matrix in Bronchopulmonary Dysplasia: Target and SourceEffect of two models of intrauterine growth restriction on alveolarization in rat lungs: morphometric and gene expression analysisResolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injuryGene expression profiling in lung fibroblasts reveals new players in alveolarizationMitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cellsKnockdown of ERp57 increases BiP/GRP78 induction and protects against hyperoxia and tunicamycin-induced apoptosis.Effects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn ratsThe Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.DA-Raf-dependent inhibition of the Ras-ERK signaling pathway in type 2 alveolar epithelial cells controls alveolar formation.Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs.Chronic lung disease in the preterm infant. Lessons learned from animal modelsPeroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease.Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration.Transglutaminase 2: a new player in bronchopulmonary dysplasia?Human bocavirus, a newly discovered parvovirus of the respiratory tract.Gene expression profiling in preterm infants: new aspects of bronchopulmonary dysplasia development.Effect of recombinant IL-10 on cultured fetal rat alveolar type II cells exposed to 65%-hyperoxia.Transcriptome analysis in prenatal IGF1-deficient mice identifies molecular pathways and target genes involved in distal lung differentiation.Lipopolysaccharide-induced injury is more pronounced in fetal transgenic ErbB4-deleted lungs.Inhaled NO as a therapeutic agentType IV collagen drives alveolar epithelial-endothelial association and the morphogenetic movements of septation.Identification of microRNAs changed in the neonatal lungs in response to hyperoxia exposure.Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.LPS-induced chorioamnionitis and antenatal corticosteroids modulate Shh signaling in the ovine fetal lung.VEGF and endothelium-derived retinoic acid regulate lung vascular and alveolar developmentTitanium oxide nanoparticle instillation induces inflammation and inhibits lung development in mice.Mitochondrial DNA damage mediates hyperoxic dysmorphogenesis in rat fetal lung explants.Regulation of alveolar septation by microRNA-489.VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn miceKey mechanisms of early lung development.Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for AlveolarizationAssociation of interferon gamma T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonatesPulmonary Biomarkers of Bronchopulmonary DysplasiaSphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteinsThe calcitriol analogue EB1089 impairs alveolarization and induces localized regions of increased fibroblast density in neonatal rat lung.Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia.Transcriptome profiling of the newborn mouse lung response to acute ozone exposure.A novel in vitro model to study alveologenesis.
P2860
Q24633128-22758319-9309-4F3E-A3B4-53D042E32B7DQ26752355-4687033C-4E50-49E4-90FA-823FFBA36D25Q26771338-5E51A3EB-16F6-4CD9-AC38-2B92158FF141Q27303463-44453C05-C394-4C64-B8D6-74C3F2DB44E7Q28539312-AEB15F95-5D36-4E12-87BB-DC5204DD807AQ28569682-7586863A-C471-4775-A6FA-DA792E58561BQ28582386-98324440-4E16-4C62-816E-386BA90D8C66Q29347120-42E01D5F-686C-4327-9550-C82C6F7AD37FQ33378441-E9355609-DABA-4653-AC0A-4A55C490C079Q33711647-3FF5F7E7-A97D-4EFF-8DB6-083A1982F95BQ33730583-180B11AD-DA50-4345-AFFA-B0A88B0E157EQ33746190-C7404F7A-DEC7-48C2-A3D2-1DE18AD485B2Q33756577-757F12D0-FBE0-46C0-9B06-6EA0788E8649Q33863173-21B4EC59-6BC0-425F-B949-5CC0632F4A1CQ34003028-BC8D9802-138D-438E-AC07-5E876CE876F9Q34417656-B120285D-AF62-4FFA-B578-9B2A905EEB04Q34934900-79DA4840-F4E2-4964-B3DB-813DAD186FDBQ35032620-09AEABDE-F9C4-45D1-A618-DA4060126370Q35044459-C284D3FD-CD77-4C3A-B81A-4B563D28560FQ35082386-70FAEF8C-BD0E-4EE5-AE91-95DDF5847FCAQ35325075-7CF88222-D100-4882-A8EB-DB61724D649BQ36003322-D9D19EB3-F6FD-46D6-B5E4-6DDC342B08F8Q36076779-7005B227-183C-4B62-B2FA-1E5068F1EEF8Q36320733-432A4055-211C-4F07-964F-98B91FD4B814Q36330521-76E49F80-EF4E-4DD5-8031-8D14503BF017Q36454401-4FE0DD83-F1CE-4F22-B0BB-EF3A88487406Q36583868-D2B97D0D-C670-477F-8C63-7A022BFFF003Q36595416-55EEEE3F-F7FD-459E-9A4B-68563B2D5BFBQ36597918-C10148E9-CD67-42CA-BC61-A37BC7FA9254Q36638457-F67308A1-7CD9-4E3A-87C6-0A33AE01B7CAQ36923908-B7D4F865-1092-49F0-812F-A0E91B9F9C08Q36968027-DC47F773-98E6-4543-830C-B2A144E8DFC9Q37088270-7A306E4B-C9E8-48E2-B038-65D8EF97A010Q37174565-CA0B468A-2C9F-4D17-B0E4-92438AAC198CQ37183717-7514F2C5-B610-46D8-A404-A37EA9F721C9Q37218785-0F132D45-D308-4E7A-A8E9-1A14485ADD86Q37355157-812A39B8-73F8-42C5-8309-4588A044A801Q37576073-B103FB38-C30A-4120-B871-09395673015DQ37595214-86E39D13-152C-4B90-9AF5-94D0C70F196AQ37596133-1DA51FF4-5C16-4FB2-8EEC-5FCA4388AB40
P2860
Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Control mechanisms of lung alv ...... in bronchopulmonary dysplasia.
@ast
Control mechanisms of lung alv ...... in bronchopulmonary dysplasia.
@en
type
label
Control mechanisms of lung alv ...... in bronchopulmonary dysplasia.
@ast
Control mechanisms of lung alv ...... in bronchopulmonary dysplasia.
@en
prefLabel
Control mechanisms of lung alv ...... in bronchopulmonary dysplasia.
@ast
Control mechanisms of lung alv ...... in bronchopulmonary dysplasia.
@en
P2093
P2860
P1433
P1476
Control mechanisms of lung alv ...... in bronchopulmonary dysplasia.
@en
P2093
Bernadette Chailley-Heu
Christophe Delacourt
Jacques Bourbon
Olivier Boucherat
P2860
P304
P356
10.1203/01.PDR.0000159630.35883.BE
P407
P433
P577
2005-04-06T00:00:00Z
P5875
P6179
1001199902